for the treatment of mild to moderate COVID-19 in India.

Business World

Glenmark introduces higher strength (400 mg) of FabiFlu(R) to reduce the pill burden of COVID-19 treatment

Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a…

Technology

Hisense Expands South India Presence Through Partnership with Sathya Agencies

Business

Piramal Finance’s Sameeksha Now Streaming on JioHotstar and Sun NXT OTT Platforms for Telangana Audiences

News

Tiger Lily Collective Launches Free 3D Areola Tattoo Program for Breast Cancer Survivors

Business

Shielded Technologies Joins Linux Foundation Decentralized Trust as Premier Member

Business

HPCL Unveils Onam 2025 Festive Campaign in Kerala